Bill > S1070

This bill mandates that starting January 1, 2027, state group health insurance plans must cover evidence-based treatments for obesity and related conditions, including intensive health behavioral and lifestyle interventions and FDA-approved weight management medications, as prescribed by a licensed provider. The coverage criteria for these medications cannot be more restrictive than the FDA's approved uses, and lifestyle interventions must align with current clinical standards of care, potentially delivered through various settings like telehealth. The Department of Management Services is required to establish specific protocols and criteria for this coverage by January 1, 2027, which will include requirements for enrollees such as being 18 or older, having a clinical diagnosis of obesity, and participating in the required interventions. The bill also defines "FDA-approved weight management medication" to specifically include certain GLP-1 agonist medications for chronic weight management and "intensive health behavioral and lifestyle intervention" as a comprehensive program for weight loss. Furthermore, the department must annually report on the participation levels and cost savings associated with these new coverage provisions.

https://www.flsenate.gov/Session/Bill/2026/1070